Trump Effect: Swiss Pharma Giant Roche to Invest $50+ Billion in U.S.
Swiss pharmaceutical giant Roche announced Tuesday it will invest upwards of $50 billion in the United States over the next five years, a move that follows in the wake of President Donald Trump’s announcement of proposed tariffs on imported drugs.
